A pulmonary infiltrate is a substance that has collected in your lung tissue where air normally sits. On a chest X-ray or CT scan, it shows up as a cloudy or hazy area because the air in tiny air sacs (alveoli) has been partially or fully replaced by fluid, pus, blood, inflammatory cells, or even cancerous tissue. The term itself isn’t a diagnosis. It’s a radiologist’s description of something abnormal on your imaging, and figuring out what’s actually causing it is the next step.
What’s Happening Inside Your Lungs
Your lungs contain millions of tiny air sacs that exchange oxygen and carbon dioxide with your blood. When those sacs fill with something other than air, the affected area becomes denser and blocks the normal passage of X-rays, creating a visible white or hazy patch on imaging. Partial filling produces what radiologists call “ground-glass opacity,” a faint haziness where you can still see the underlying lung structures through the cloudiness. Complete filling produces “consolidation,” a dense white area where air has been entirely displaced.
The material doing the filling varies widely depending on the cause. In pneumonia, it’s typically pus and inflammatory fluid. In pulmonary edema (fluid backup from heart problems), it’s watery fluid leaking from blood vessels. In rarer conditions, it can be blood from a hemorrhage, clusters of cancer cells, or immune cells that have flooded the area in response to an allergic or autoimmune reaction.
Common Causes
Infection is by far the most frequent reason for a pulmonary infiltrate. In one large study of immunocompromised patients with new infiltrates on imaging, 72% turned out to have pneumonia. Bacterial infections led the list, followed by fungal and then viral causes. Among otherwise healthy people, community-acquired bacterial pneumonia is the most common culprit.
Noninfectious causes account for a smaller but important share. These include:
- Pulmonary edema: fluid buildup from heart failure or kidney problems
- Diffuse alveolar hemorrhage: bleeding into the air sacs, sometimes from autoimmune conditions
- Cancer: lung tumors or cancers that have spread to the lungs from elsewhere
- Drug reactions: certain chemotherapy agents and other medications can cause lung inflammation
- Organizing pneumonia: an inflammatory condition where the body’s repair process causes tissue to fill the air sacs, unrelated to active infection
Lung adenocarcinoma, one of the more common types of lung cancer, can occasionally mimic pneumonia on imaging by appearing as diffuse ground-glass patches rather than a distinct mass. In people without a smoking history, this pattern sometimes gets initially misdiagnosed as an infection, which can delay cancer detection.
Symptoms You Might Notice
Cough and shortness of breath are the two most common symptoms when infiltrates are present. The cough may be dry or may produce mucus, depending on the cause. You might also experience fever and chills if infection is involved, chest pain that worsens with deep breathing, or fatigue that seems out of proportion to your activity level.
On physical exam, a doctor listening with a stethoscope may hear crackling sounds (called crackles) in the affected area, or notice that breath sounds are diminished on one side. Some infiltrates, particularly small ones or those that develop slowly, produce no symptoms at all and are discovered incidentally on imaging done for another reason.
Focal vs. Diffuse Patterns
Where the infiltrate sits in your lungs and how widespread it is gives doctors important clues about the cause. A focal infiltrate, concentrated in one area or one lobe, most often points to bacterial pneumonia or a localized tumor. Diffuse infiltrates, spread across both lungs, suggest a systemic process: heart failure, a widespread infection, an autoimmune reaction, or, less commonly, cancers like lymphoma or leukemia that scatter through lung tissue.
The distinction matters because it shapes how urgently your doctor pursues a diagnosis and which tests come next. Bilateral, rapidly worsening infiltrates raise concern for acute respiratory distress syndrome (ARDS), a serious condition where widespread inflammation causes the lungs to fill with fluid and oxygen levels to drop dangerously.
How Doctors Figure Out the Cause
The diagnostic process starts with your history and a physical exam, followed by chest imaging. A standard chest X-ray is usually the first look, but a CT scan provides much more detail about the pattern, location, and extent of the infiltrate.
Blood tests help narrow things down. Blood cultures can identify bacteria circulating in the bloodstream. Inflammatory markers like C-reactive protein (CRP) and procalcitonin help distinguish infection from noninfectious inflammation. Procalcitonin in particular rises in proportion to the severity of bacterial infection, making it useful for gauging how serious an infection is and tracking whether treatment is working. CRP responds more slowly and plateaus earlier, so it’s a better general indicator of inflammation but less precise for grading severity.
If initial testing doesn’t provide a clear answer, the next step is often bronchoscopy, a procedure where a thin, flexible camera is guided into the airways. Fluid can be washed into a section of the lung and then collected (bronchoalveolar lavage) to test for bacteria, fungi, viruses, and abnormal cells. When even that doesn’t yield a diagnosis, a tissue biopsy may be needed, either through a needle guided by CT imaging or through a small surgical procedure.
Treatment Depends on the Cause
Because “pulmonary infiltrate” describes a finding rather than a specific disease, treatment targets whatever is producing it. Bacterial pneumonia is treated with antibiotics. Viral pneumonia may require antiviral medications or, in many cases, supportive care while the immune system clears the infection. Pulmonary edema from heart failure responds to diuretics that pull excess fluid out of the lungs and adjustments to heart medications.
Corticosteroids play a role in several scenarios. For severe pneumonia, particularly cases progressing toward respiratory failure, adding corticosteroids to antibiotic therapy has been shown to reduce the need for mechanical ventilation, shorten hospital stays, and lower the risk of ARDS. The benefit is most pronounced in patients with elevated inflammatory markers and when steroids are started within the first 48 hours. For infiltrates caused by autoimmune inflammation or eosinophilic pneumonia (a condition driven by a specific type of immune cell), steroids are often the primary treatment.
Cancer-related infiltrates require oncologic treatment, whether that’s chemotherapy, targeted therapy, or radiation, depending on the type and stage. Drug-induced infiltrates typically improve once the offending medication is stopped, sometimes with a course of steroids to calm residual inflammation.
When Infiltrates Don’t Resolve
Most infiltrates from common infections clear within a few weeks with appropriate treatment. Your doctor may repeat imaging after several weeks to confirm the infiltrate is shrinking. An infiltrate that persists or worsens despite treatment raises a red flag for a resistant infection, an unusual organism, or a noninfectious cause that was initially missed.
Unresolved infiltrates can lead to complications. Ongoing infection in the lungs can progress to ARDS, where severe inflammation causes widespread fluid accumulation and potentially life-threatening drops in oxygen. Pulmonary infections complicating ARDS significantly worsen outcomes and lengthen time spent on a ventilator. Chronic or repeated infiltrates can also lead to scarring (fibrosis) that permanently reduces lung capacity. If a follow-up X-ray shows an infiltrate that hasn’t cleared on the expected timeline, your doctor will likely order additional testing or a CT scan to look more closely at what’s going on.